Real-world experience with Ropeginterferon-alpha 2b (Besremi) in Philadelphia-negative myeloproliferative neoplasms - Concepedia

Concepedia

Publication | Open Access

Real-world experience with Ropeginterferon-alpha 2b (Besremi) in Philadelphia-negative myeloproliferative neoplasms

DOI Full Paper Access

27

Citations

20

References

2020

Year

Cih‐En Huang, Yuying Wu, Chia‐Chen Hsu, Ying‐Ju Chen, Hsing-Yi Tsou, Chian-Pei Li, Yi‐Hua Lai, Chang‐Hsien Lu, Ping‐Tsung Chen, Chih‐Cheng Chen

Journal of the Formosan Medical Association

Abstract

Conclusively, observed signs of efficacy and safety in our real-world experience prove Ropeg as a promising option for the treatment of MPN.

References

	Year	Citations

Page 1